Antibiotics commonly used to treat mastitis and respiratory burst of bovine polymorphonuclear leukocytes.
The in vitro effects of six doses (2 x 10(-3) to 2 x 10(-8) M) of antimicrobial drugs that are frequently used in udder infusions on the capacity of bovine blood polymorphonuclear neutrophilic leukocytes to generate reactive oxygen species were studied by the measurement of luminol-dependent chemiluminescence after stimulation with phorbol 12-myristate 13-acetate. All drugs, except cloxacillin, significantly decreased chemiluminescence at the highest dose. Doxycyline induced the most severe inhibition, followed by neomycin and dihydrostreptomycin. The effect of ampicillin was due to the scavenging of reactive oxygen species and interactions with luminol. The inhibition observed with oleandomycin, neomycin, lincomycin, and dihydrostreptomycin was not due to direct effects on the production of oxidative metabolites but rather to interference with other components involved in the production of light, such as interference with the interaction between luminol and the myeloper-oxidase-H2O2-halide system. The deleterious effects of doxycycline can be explained by several factors: decreased production of superoxide, yellow color, the scavenging of reactive oxygen species, and Ca2+ chelating effect. In conclusion, the results of this study show that antibiotics may affect neutrophil function at concentrations that are reached in the mammary gland after local and repeated administration.
Hoeben
D
D
Department of Physiology, Biochemistry, and Biometrics, Faculty of Veterinary Medicine, University of Gent, Merelbeke, Belgium.
Burvenich
C
C
Heyneman
R
R
D000667:Ampicillin / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002417:Cattle / Q000097:blood*; D004096:Dihydrostreptomycin Sulfate / Q000494:pharmacology; D004318:Doxycycline / Q000494:pharmacology; D005260:Female; D006997:Hypochlorous Acid / Q000737:chemistry; D008034:Lincomycin / Q000494:pharmacology; D008163:Luminescent Measurements; D008165:Luminol / Q000737:chemistry / Q000494:pharmacology; D008414:Mastitis, Bovine / Q000188:drug therapy*; D009355:Neomycin / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D009827:Oleandomycin / Q000494:pharmacology; D009195:Peroxidase / Q000097:blood; D016897:Respiratory Burst / Q000187:drug effects*; D013481:Superoxides / Q000097:blood; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D013481:Superoxides; D008165:Luminol; D006997:Hypochlorous Acid; D000667:Ampicillin; D008034:Lincomycin; D009195:Peroxidase; D009355:Neomycin; D004318:Doxycycline; D013755:Tetradecanoylphorbol Acetate; D009827:Oleandomycin; D004096:Dihydrostreptomycin Sulfate